EP0998958A2 - Système pour une stimulation cérébrale optimisée - Google Patents

Système pour une stimulation cérébrale optimisée Download PDF

Info

Publication number
EP0998958A2
EP0998958A2 EP99120925A EP99120925A EP0998958A2 EP 0998958 A2 EP0998958 A2 EP 0998958A2 EP 99120925 A EP99120925 A EP 99120925A EP 99120925 A EP99120925 A EP 99120925A EP 0998958 A2 EP0998958 A2 EP 0998958A2
Authority
EP
European Patent Office
Prior art keywords
lead
electrode
feedback
brain
dbs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP99120925A
Other languages
German (de)
English (en)
Other versions
EP0998958B1 (fr
EP0998958A3 (fr
Inventor
Frans L.H. Gielen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Inc
Original Assignee
Medtronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Inc filed Critical Medtronic Inc
Publication of EP0998958A2 publication Critical patent/EP0998958A2/fr
Publication of EP0998958A3 publication Critical patent/EP0998958A3/fr
Application granted granted Critical
Publication of EP0998958B1 publication Critical patent/EP0998958B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128—Control systems
    • A61N1/36146—Control systems specified by the stimulation parameters
    • A61N1/36182—Direction of the electrical field, e.g. with sleeve around stimulating electrode
    • A61N1/36185—Selection of the electrode configuration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36067—Movement disorders, e.g. tremor or Parkinson disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128—Control systems
    • A61N1/36146—Control systems specified by the stimulation parameters
    • A61N1/3615—Intensity
    • A61N1/36153—Voltage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0526—Head electrodes
    • A61N1/0529—Electrodes for brain stimulation
    • A61N1/0534—Electrodes for deep brain stimulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128—Control systems
    • A61N1/36146—Control systems specified by the stimulation parameters
    • A61N1/36167—Timing, e.g. stimulation onset

Definitions

  • This invention lies in the field of systems for brain stimulation and recording of brain activity and, more particularly, systems for placement of the lead for stimulating and/or recording at an optimized physiological brain target, for the treatment of conditions such as movement disorders.
  • Deep Brain Stimulation has been found to be successful in treating a variety of brain-controlled disorders, including movement disorders.
  • DBS Deep Brain Stimulation
  • Such treatment involves placement of DBS type lead through a burr hole drilled in the patient's skull, followed by placement of the lead and then applying appropriate stimulation through the lead to the physiological target.
  • the placement portion of the treatment is very critical, and has been the subject of much attention and research.
  • finding the deep brain target and then placing the permanent lead so that it efficiently stimulates such target is very important. See, for example, U.S. Patent Application Serial. No. 09/009,247, filed January 20, 1998, Gielen et al, which deals with the localization procedure in functional stereotactic brain surgery, i.e., the initial probing to find the optimum site for delivering the stimulation.
  • Finding the optimal physiological target in deep brain stimulation implants for the treatment of movement disorders is a particularly complicated task. This is especially true for the treatment of symptoms which cannot be tested at the operating table during lead implant. For instance, it is impossible to test walking and postural stability in Parkinson's Disease (PD) patients during DBS lead implant. Two other major PD symptoms, Rigidity and Akinesia, are also considered difficult to evaluate quantitatively during DBS lead implant. Thus far, no reliable quantitative evaluation procedures exist that can be performed during the surgical DBS implant procedure for these major symptoms.
  • PD Parkinson's Disease
  • trans-cranial magnetic stimulation coil cannot be accessed to the relevant sites of the brain when the DBS lead is being held by the stereotactic equipment. This means that the Leone procedure is not directly suggested for use in evaluating the excitability of the relevant motor cortex areas during lead implant. Thus, while the prior art procedure is appropriate for certain post-surgical testing because it is non-invasive, it is not suggested for intra-operative use.
  • the continued need in the art is a system and procedure that can be utilized during surgery when the DBS lead is being implanted, to determine when it has been placed in the optimal position for stimulation therapy of the patient's particular disorder, or for recording of brain activity.
  • the aim is a system for stimulation of the GPi or other neuro-stimulation target, and a feedback target such as the MC.
  • a key to this invention is the recognition that during surgery, there is no need for a non-invasive way of stimulating the feedback target.
  • the invention rather, provides apparatus for testing for the optimal DBS electrode position during the invasive surgery, and as part of the localization test procedure that is required in any event, enabling a reliable determination of optimal lead placement before permanent lead implant and close of surgery.
  • a primary object of this invention is to provide a system for determining with a test lead or permanent lead when a brain electrode is positioned optimally so during stimulation of the brain target normal patient excitability of a feedback target such as the motor cortex achieves the desired result, e.g., the desired body movement of a patient with a movement disorder.
  • another object is to provide an improved capacity to record brain activity.
  • the invention takes advantage of the fact that during DBS lead implant, the patient's brain is already subject to an invasive procedure. This being the case, both the neuro-modulation target and the feedback target can be readily stimulated during surgery.
  • the stimulation of the motor cortex concurrently with the GPi need not be limited to a non-invasive technique.
  • the invention provides a brain stimulation system, comprising a brain stimulator or device and lead means for placement of electrodes at predetermined positions within a patient's brain, said brain stimulator device having first pulse means for generating feedback pulses for stimulating a feedback target in the patient's brain and second pulse means for generating DBS pulses for stimulating a neuro-modulation target in said patient's brain; and said lead means being connected to said device for conducting said pulses from said device to said respective targets, said lead means comprising a DBS electrode and a conductor for conducting said DBS pulses from said second pulse means to said DBS electrode, a feedback electrode and a conductor for connecting said feedback pulses from said first pulse means to said feedback electrode, and said DBS and feedback pulses from said first pulse means to said feedback electrode, and said DBS and feedback electrodes being positioned on said lead means relative to each other so that when said DBS electrode is positioned at said neuro-stimulation target said feedback electrode is positioned at said feedback target.
  • a lead for providing stimulation of both a feedback target in a patient's brain and a neuro-modulation target in the patient's brain said lead also providing for recording of brains signals from either of said targets, said lead having proximal and distal ends, comprising:
  • the optimal DBS target location can be found. Also, either or both of the electrodes can be used for recording brain activity.
  • the test lead is removed and a permanent lead positioned so that the DBS electrode(s) is located at the optimal target position.
  • the permanent lead also preferably is aligned along the linear trajectory which includes both the neuro-modulation and the feedback targets, and carries electrodes for stimulating or recording at both targets, thereby enabling post-operative testing.
  • the system preferably includes a generator device with dual stimulus pulse channels for providing stimuli with appropriate parameters for stimulating the respective targets, and sense channels for amplifying and processing detected brain signals.
  • FIG. 1 there is shown a diagram of a patient's head, with burr holes BH-A and BH-B shown drilled through the patient's skull to allow entry beneath the dura. While Figure 1 presents an illustration of the specific MC/GPi embodiment, it is to be understood that the principles involved are equally applicable to other targets, as discussed above.
  • a normal trajectory would be that indicated through the hole BH-A, along trajectory A, to the GPi.
  • the motor cortex MC is not along this line.
  • burr hole BH-B is utilized, to provide a trajectory as indicated along indicated line B.
  • the lead of this invention preferably includes an adjustable electrode location for stimulating the feedback target, e.g., the MC, when the distal electrodes are in place for stimulating the GPi or other brain target.
  • Stimulator device 30 may be, for example, a Medtronic Model 3628, or a modification thereof; and the lead may be a modification of Medtronic InterStim Model 4300 or Medtronic DBS Lead Model 3387.
  • the stimulator device contains two pulse generation channels, channel 1 indicated at 32 and channel 2 at 34. Each of these channels is controlled by control block 35, which may appropriately utilize a microprocessor and/or other control and timing circuitry.
  • the lead proximal end 41 is connected to the outputs of the device 30.
  • Channel 1 connects to one or more lead conductors which provide electrical connection to distal electrodes indicated at 46 near the lead distal end 42. These electrodes are positioned at the neuro-modulation target, e.g., the GPi.
  • the pulses generated by channel 1 and delivered to the deep brain location are, for example, pulses of 60-120 ⁇ S pulse width, typically delivered at a rate in the range of about 50-250 Hz, and with a pulse amplitude of about 1-10 v.
  • the signals delivered by channel 2 are connected through to electrode 44, which is shown positioned proximally from electrodes 46, and at a distance in the neighborhood of 3-8 cm from the distal electrodes 46, depending on the application.
  • the positioning of electrode 44 is designed to place it proximate to the motor cortex when the distal electrodes 46 are positioned at the GPi brain target.
  • the pulses delivered by channel 2 are, e.g., pulses of a width 1-10 ms, delivered at a rate of 1 to 5 Hz and with a voltage in the range of 1-10 v.
  • Signals received from the electrodes are processed at sense channels 37,38 and stored at 39.
  • electrode 44 is suitably comprised of a series of smaller ring electrodes, as indicated at 48, the purpose of this design being to achieve a greater lead flexibility.
  • the electrode 44 may be one integral ring electrode, providing a large surface extending around the tubular body 43 of lead 40.
  • a sliding tubing, or sleeve 50 Shown above the lead portion carrying electrode 44 is a sliding tubing, or sleeve 50, being a hollow tubing having an inner diameter adapted to just fit over the outer diameter of lead body 43.
  • Tubing 50 is made of an electrically insulative material coating 51, except at a window portion 52 of predetermined length.
  • the tubing 50 extends proximally a sufficient distance so that it can be manipulated, i.e., slid along the lead 43 so as to position the window portion 52 relative to the lead.
  • the tubing is illustrated as having been slid down to register with a portion of the rings 48, providing an electrode which is adjustable along the axis of the lead by positioning of the window.
  • the test is initiated by providing a test lead as discussed in connection with Figures 2 through 3B above.
  • a test lead is provided with respective MC and GPi electrodes, where the position of the MC electrode is preferably adjustable to account for required patient variations in inter-electrode distance, as discussed in connection with Figure 1.
  • the location of the GPi and the MC are then preliminarily determined, as indicated at 62.
  • the approximate location of the GPi can be determined non-invasively; a more exact location of the GPi target can be determined as discussed in the above referenced U.S. Patent Application Serial No.
  • the location of the MC can be determined, e.g., by trans-cranial magnetic stimulation. With this information having been obtained, the desired one-dimensional trajectory through the two targets is known.
  • a burr hole is drilled to provide entry through the skull for the desired linear trajectory. Note that if a first burr hole is drilled in order to perform the initial localization, it can be used for placement of a separate lead to the GPi, as discussed above.
  • the test lead is stereotactically introduced along the trajectory, and the distal DBS electrode positioned in the area of the GPi.
  • the position of the MC electrode 44 is adjusted, e.g., in the manner suggested by the discussion of Figures 3A, B.
  • the positioning of electrode 44 with respect to the MC will, of course, depend upon what body portion is to be tested or treated.
  • the two targets are stimulated, and the relevant body movement, or lack thereof, is noted. This provides the feedback for determining when the DBS electrode has been optimally located. Also, at 68, brain activity at the two sites can be recorded.
  • the DBS electrode complex 46 is optimally located. If no, which would include a state of uncertainty, the position of the DBS electrode is adjusted, as shown at 72, and then the stimulation is repeated, as indicated by the branch that loops back to 68. When the physician is satisfied that an optimal position has been found, the test is concluded, and the permanent lead is implanted, as indicated at 74. The lead is then attached to the generator device, and the patient is chronically stimulated, as indicated at 76. As mentioned above, by providing a permanent lead that also has an MC electrode, and is placed along the trajectory that encompasses both targets, subsequent tests can be conducted. Further, brain signal recordings can be obtained from the electrode sites, either concurrently, or at one site during stimulation of the other site.
  • a system for stimulating or recording at dual sites in a patient's brain e.g., a feedback site such as the motor cortex, and a deep brain or neuro-modulation site such as the GPi.
  • a feedback site such as the motor cortex
  • a deep brain or neuro-modulation site such as the GPi.
  • the preferred embodiment has been presented as a single lead, either a test or permanent lead, it is to be understood that the invention can likewise be practiced by insertion of two leads, e.g., one for positioning of an electrode at the motor cortex and one for positioning of an electrode at the GPi.
  • the term "electrode” means either a single electrode or a plurality of electrodes, as illustrated in Figures 2 and 3A.

Landscapes

  • Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Electrotherapy Devices (AREA)
EP99120925A 1998-11-05 1999-11-02 Système pour une stimulation cérébrale optimisée Expired - Lifetime EP0998958B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/186,490 US6253109B1 (en) 1998-11-05 1998-11-05 System for optimized brain stimulation
US186490 1998-11-05

Publications (3)

Publication Number Publication Date
EP0998958A2 true EP0998958A2 (fr) 2000-05-10
EP0998958A3 EP0998958A3 (fr) 2000-12-27
EP0998958B1 EP0998958B1 (fr) 2005-08-03

Family

ID=22685162

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99120925A Expired - Lifetime EP0998958B1 (fr) 1998-11-05 1999-11-02 Système pour une stimulation cérébrale optimisée

Country Status (3)

Country Link
US (2) US6253109B1 (fr)
EP (1) EP0998958B1 (fr)
DE (1) DE69926465T2 (fr)

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6959215B2 (en) * 2002-12-09 2005-10-25 Northstar Neuroscience, Inc. Methods for treating essential tremor
US7010351B2 (en) 2000-07-13 2006-03-07 Northstar Neuroscience, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US7104947B2 (en) 2003-11-17 2006-09-12 Neuronetics, Inc. Determining stimulation levels for transcranial magnetic stimulation
US7107104B2 (en) 2003-05-30 2006-09-12 Medtronic, Inc. Implantable cortical neural lead and method
EP1341579B1 (fr) * 2000-12-07 2006-11-29 Medtronic, Inc. Stimulation directionnelle du cerveau et broches de raccordement
US7651459B2 (en) 2004-01-06 2010-01-26 Neuronetics, Inc. Method and apparatus for coil positioning for TMS studies
US7672730B2 (en) 2001-03-08 2010-03-02 Advanced Neuromodulation Systems, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US7684866B2 (en) 2003-08-01 2010-03-23 Advanced Neuromodulation Systems, Inc. Apparatus and methods for applying neural stimulation to a patient
US7756584B2 (en) 2000-07-13 2010-07-13 Advanced Neuromodulation Systems, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US7831305B2 (en) 2001-10-15 2010-11-09 Advanced Neuromodulation Systems, Inc. Neural stimulation system and method responsive to collateral neural activity
US7856264B2 (en) 2005-10-19 2010-12-21 Advanced Neuromodulation Systems, Inc. Systems and methods for patient interactive neural stimulation and/or chemical substance delivery
US8088058B2 (en) 2005-01-20 2012-01-03 Neuronetics, Inc. Articulating arm
US8128549B2 (en) 2007-02-20 2012-03-06 Neuronetics, Inc. Capacitor failure detection
US8177702B2 (en) 2004-04-15 2012-05-15 Neuronetics, Inc. Method and apparatus for determining the proximity of a TMS coil to a subject's head
US8517908B2 (en) 2003-03-07 2013-08-27 Neuronetics, Inc. Reducing discomfort caused by electrical stimulation
US8657731B2 (en) 2005-07-27 2014-02-25 Neuronetics, Inc. Magnetic core for medical procedures
EP2892419A4 (fr) * 2012-09-10 2016-11-02 Great Lakes Neuro Technologies Inc Système, dispositifs et procédés de thérapie de trouble du mouvement, et procédés intelligents de réglage
US9884200B2 (en) 2008-03-10 2018-02-06 Neuronetics, Inc. Apparatus for coil positioning for TMS studies
JP2018516149A (ja) * 2015-05-31 2018-06-21 サルーダ・メディカル・ピーティーワイ・リミテッド 脳神経刺激装置電極の取付け
US10039507B2 (en) 2012-09-19 2018-08-07 The Regents Of The University Of Michigan Advanced intraoperative neural targeting system and method
US10315041B2 (en) 2005-05-17 2019-06-11 Neuronetics, Inc. Ferrofluidic cooling and acoustical noise reduction in magnetic stimulators
US10368762B2 (en) 2014-05-05 2019-08-06 Saluda Medical Pty Ltd. Neural measurement
US10413745B2 (en) 2003-03-07 2019-09-17 Neuronetics, Inc. Reducing discomfort caused by electrical stimulation
US10426409B2 (en) 2013-11-22 2019-10-01 Saluda Medical Pty Ltd Method and device for detecting a neural response in a neural measurement
US11344729B1 (en) 2014-12-11 2022-05-31 Saluda Medical Pty Ltd Method and device for feedback control of neural stimulation
US11413460B2 (en) 2011-05-13 2022-08-16 Saluda Medical Pty Ltd Method and apparatus for application of a neural stimulus
US11786729B2 (en) 2004-07-15 2023-10-17 Advanced Neuromodulation Systems, Inc. Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy
US11944439B2 (en) 2012-11-06 2024-04-02 Saluda Medical Pty Ltd Method and system for controlling electrical conditions of tissue
US11944440B2 (en) 2011-05-13 2024-04-02 Saluda Medical Pty Ltd Method and apparatus for estimating neural recruitment

Families Citing this family (252)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6463328B1 (en) * 1996-02-02 2002-10-08 Michael Sasha John Adaptive brain stimulation method and system
US20060217782A1 (en) * 1998-10-26 2006-09-28 Boveja Birinder R Method and system for cortical stimulation to provide adjunct (ADD-ON) therapy for stroke, tinnitus and other medical disorders using implantable and external components
US7062330B1 (en) * 1998-10-26 2006-06-13 Boveja Birinder R Electrical stimulation adjunct (Add-ON) therapy for urinary incontinence and urological disorders using implanted lead stimulus-receiver and an external pulse generator
US6539263B1 (en) * 1999-06-11 2003-03-25 Cornell Research Foundation, Inc. Feedback mechanism for deep brain stimulation
US6587724B2 (en) * 1999-12-17 2003-07-01 Advanced Bionics Corporation Magnitude programming for implantable electrical stimulator
US20050055064A1 (en) * 2000-02-15 2005-03-10 Meadows Paul M. Open loop deep brain stimulation system for the treatment of Parkinson's Disease or other disorders
US7305268B2 (en) 2000-07-13 2007-12-04 Northstar Neurscience, Inc. Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators
US7024247B2 (en) 2001-10-15 2006-04-04 Northstar Neuroscience, Inc. Systems and methods for reducing the likelihood of inducing collateral neural activity during neural stimulation threshold test procedures
US7236831B2 (en) * 2000-07-13 2007-06-26 Northstar Neuroscience, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US6871098B2 (en) * 2000-10-30 2005-03-22 Medtronic, Inc. Method for treating obsessive-compulsive disorder with electrical stimulation of the brain internal capsule
US7013177B1 (en) 2001-07-05 2006-03-14 Advanced Bionics Corporation Treatment of pain by brain stimulation
US7110820B2 (en) * 2002-02-05 2006-09-19 Tcheng Thomas K Responsive electrical stimulation for movement disorders
DE10211766B4 (de) * 2002-03-14 2004-07-01 Forschungszentrum Jülich GmbH Vorrichtung zur Behandlung von Patienten mittels Hirnstimulation sowie die Verwendung der Vorrichtung in der Medizin
US7221981B2 (en) 2002-03-28 2007-05-22 Northstar Neuroscience, Inc. Electrode geometries for efficient neural stimulation
US7295880B2 (en) * 2002-04-29 2007-11-13 Medtronic, Inc. Stimulation control for brain stimulation
WO2003098268A1 (fr) * 2002-05-17 2003-11-27 Musc Foundation For Research Development Procede, appareil et systeme pour le positionnement automatique d'une sonde ou d'un capteur
US20040024425A1 (en) * 2002-07-31 2004-02-05 Worley Seth J. Method and apparatus for using a cardiac stimulating, sensing and guidewire combination
US6717804B1 (en) * 2002-09-30 2004-04-06 Hewlett-Packard Development Company, L.P. Light-emitting lock device control element and electronic device including the same
US20050049649A1 (en) * 2002-10-21 2005-03-03 The Cleveland Clinic Foundation Electrical stimulation of the brain
US7236830B2 (en) * 2002-12-10 2007-06-26 Northstar Neuroscience, Inc. Systems and methods for enhancing or optimizing neural stimulation therapy for treating symptoms of Parkinson's disease and/or other movement disorders
US20050075680A1 (en) 2003-04-18 2005-04-07 Lowry David Warren Methods and systems for intracranial neurostimulation and/or sensing
EP1581102A4 (fr) * 2002-12-11 2006-12-20 Proteus Biomedical Inc Procede et systeme permettant de controler et traiter des parametres hemodynamiques
EP1624921A4 (fr) * 2003-04-28 2008-12-31 Univ Vanderbilt Appareil et procedes de positionnement optimal d'un stimulateur cerebral profond
US20040225335A1 (en) * 2003-05-08 2004-11-11 Whitehurst Todd K. Treatment of Huntington's disease by brain stimulation
US7149574B2 (en) 2003-06-09 2006-12-12 Palo Alto Investors Treatment of conditions through electrical modulation of the autonomic nervous system
US7738952B2 (en) * 2003-06-09 2010-06-15 Palo Alto Investors Treatment of conditions through modulation of the autonomic nervous system
US20050143378A1 (en) * 2003-12-29 2005-06-30 Yun Anthony J. Treatment of conditions through pharmacological modulation of the autonomic nervous system
US20050153885A1 (en) * 2003-10-08 2005-07-14 Yun Anthony J. Treatment of conditions through modulation of the autonomic nervous system
US9050469B1 (en) 2003-11-26 2015-06-09 Flint Hills Scientific, Llc Method and system for logging quantitative seizure information and assessing efficacy of therapy using cardiac signals
US8060207B2 (en) * 2003-12-22 2011-11-15 Boston Scientific Scimed, Inc. Method of intravascularly delivering stimulation leads into direct contact with tissue
US20050137646A1 (en) 2003-12-22 2005-06-23 Scimed Life Systems, Inc. Method of intravascularly delivering stimulation leads into brain
US7676269B2 (en) * 2003-12-29 2010-03-09 Palo Alto Investors Treatment of female fertility conditions through modulation of the autonomic nervous system
US7647097B2 (en) * 2003-12-29 2010-01-12 Braingate Co., Llc Transcutaneous implant
ATE523141T1 (de) 2004-02-17 2011-09-15 Philips Electronics Ltd Verfahren und vorrichtung zur registrierung, verifizierung von und bezugnahme auf körperorgane(n)
WO2005087314A1 (fr) * 2004-03-11 2005-09-22 Advanced Neuromodulation Systems, Inc. Systeme et procede de stimulation du cerveau
US7177702B2 (en) 2004-03-12 2007-02-13 Scimed Life Systems, Inc. Collapsible/expandable electrode leads
US7590454B2 (en) 2004-03-12 2009-09-15 Boston Scientific Neuromodulation Corporation Modular stimulation lead network
US20050203600A1 (en) 2004-03-12 2005-09-15 Scimed Life Systems, Inc. Collapsible/expandable tubular electrode leads
US20050246003A1 (en) * 2004-04-28 2005-11-03 Advanced Neuromodulation Systems, Inc. Stimulation lead having pairs of stimulating electrodes spaced at different distances for providing electrical stimulation to different nerve tissues
US7231260B2 (en) 2004-05-06 2007-06-12 Boston Scientific Scimed, Inc. Intravascular self-anchoring electrode body with arcuate springs, spring loops, or arms
US7899527B2 (en) * 2004-05-13 2011-03-01 Palo Alto Investors Treatment of conditions through modulation of the autonomic nervous system during at least one predetermined menstrual cycle phase
US20100260669A1 (en) * 2004-05-13 2010-10-14 Anthony Joonkyoo Yun Treatment of Seasonal Conditions Through Modulation of the Autonomic Nervous System
US7601115B2 (en) * 2004-05-24 2009-10-13 Neuronetics, Inc. Seizure therapy method and apparatus
US7346382B2 (en) 2004-07-07 2008-03-18 The Cleveland Clinic Foundation Brain stimulation models, systems, devices, and methods
US7286879B2 (en) 2004-07-16 2007-10-23 Boston Scientific Scimed, Inc. Method of stimulating fastigium nucleus to treat neurological disorders
US8569277B2 (en) 2004-08-11 2013-10-29 Palo Alto Investors Methods of treating a subject for a condition
US20090105521A1 (en) * 2004-09-13 2009-04-23 Jonathan Bentwich Systems and methods for assessing and treating medical conditions related to the central nervous system and for enhancing cognitive functions
US20090099623A1 (en) * 2004-09-13 2009-04-16 Neuronix Ltd. Systems and methods for treatment of medical conditions related to the central nervous system and for enhancing cognitive functions
US20060058853A1 (en) * 2004-09-13 2006-03-16 Jonathan Bentwich Integrated system and method for treating disease using cognitive-training and brain stimulation and computerized magnetic photo-electric stimulator (cmpes)
US20060161216A1 (en) * 2004-10-18 2006-07-20 John Constance M Device for neuromuscular peripheral body stimulation and electrical stimulation (ES) for wound healing using RF energy harvesting
US7857746B2 (en) * 2004-10-29 2010-12-28 Nueronetics, Inc. System and method to reduce discomfort using nerve stimulation
DE602005019092D1 (de) 2004-11-05 2010-03-11 Us Gov Health & Human Serv Zugangssystem
US7565200B2 (en) 2004-11-12 2009-07-21 Advanced Neuromodulation Systems, Inc. Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects
KR100689707B1 (ko) * 2004-11-12 2007-03-08 삼성전자주식회사 뱅크 선택신호 제어회로, 이를 포함하는 반도체 메모리 장치 및 뱅크 선택신호 제어방법
US7751868B2 (en) 2004-11-12 2010-07-06 Philips Electronics Ltd Integrated skin-mounted multifunction device for use in image-guided surgery
US7805269B2 (en) 2004-11-12 2010-09-28 Philips Electronics Ltd Device and method for ensuring the accuracy of a tracking device in a volume
US7937160B2 (en) 2004-12-10 2011-05-03 Boston Scientific Neuromodulation Corporation Methods for delivering cortical electrode leads into patient's head
US7366571B2 (en) * 2004-12-10 2008-04-29 Cyberonics, Inc. Neurostimulator with activation based on changes in body temperature
US20060136007A1 (en) * 2004-12-21 2006-06-22 Mickle Marlin H Deep brain stimulation apparatus, and associated methods
US7957793B2 (en) 2004-12-22 2011-06-07 Wisconsin Alumni Research Foundation Methods for identifying neuronal spikes
WO2006069250A2 (fr) * 2004-12-22 2006-06-29 Wisconsin Alumni Research Foundation Techniques et dispositifs d'analyse de donnees groupees concernant en particulier des potentiels d'action (tels que des signaux de decharges neuronales dans le cerveau)
US8515541B1 (en) 2004-12-22 2013-08-20 Boston Scientific Neuromodulation Corporation Methods and systems for treating post-stroke disorders
WO2006074029A2 (fr) * 2005-01-06 2006-07-13 Cyberkinetics Neurotechnology Systems, Inc. Systemes ambulatoires de patients a dispositifs multiples et a commande neurale et procedes associes
WO2006078677A2 (fr) 2005-01-18 2006-07-27 Traxtal Technologies Inc. Dispositif a fil k guide electromagnetiquement
WO2006078678A2 (fr) 2005-01-18 2006-07-27 Traxtal Inc. Methode et appareil de guidage d'un instrument jusqu'a une region cible d'un poumon
US8565867B2 (en) 2005-01-28 2013-10-22 Cyberonics, Inc. Changeable electrode polarity stimulation by an implantable medical device
US8260426B2 (en) 2008-01-25 2012-09-04 Cyberonics, Inc. Method, apparatus and system for bipolar charge utilization during stimulation by an implantable medical device
US9314633B2 (en) 2008-01-25 2016-04-19 Cyberonics, Inc. Contingent cardio-protection for epilepsy patients
US20060173493A1 (en) * 2005-01-28 2006-08-03 Cyberonics, Inc. Multi-phasic signal for stimulation by an implantable device
DE602006010515D1 (de) 2005-01-31 2009-12-31 Medtronic Inc Verfahren zur herstellung einer medizinischen leitung
US8430888B2 (en) 2005-02-22 2013-04-30 Boston Scientific Neuromodulation Corporation Minimally invasive methods for locating an optimal location for deep brain stimulation
US7369899B2 (en) * 2005-02-22 2008-05-06 Boston Scientific Neuromodulation Corporation Minimally invasive systems for locating an optimal location for deep brain stimulation
US7657316B2 (en) * 2005-02-25 2010-02-02 Boston Scientific Neuromodulation Corporation Methods and systems for stimulating a motor cortex of the brain to treat a medical condition
US20060199159A1 (en) * 2005-03-01 2006-09-07 Neuronetics, Inc. Head phantom for simulating the patient response to magnetic stimulation
US7421297B2 (en) * 2005-03-31 2008-09-02 Medtronic, Inc. Monopolar stimulation assembly including at least one remote electrode
US8112154B2 (en) * 2005-04-13 2012-02-07 The Cleveland Clinic Foundation Systems and methods for neuromodulation using pre-recorded waveforms
US9211408B2 (en) 2005-04-13 2015-12-15 The Cleveland Clinic Foundation System and method for neuromodulation using composite patterns of stimulation or waveforms
US9339650B2 (en) 2005-04-13 2016-05-17 The Cleveland Clinic Foundation Systems and methods for neuromodulation using pre-recorded waveforms
CA2612603C (fr) 2005-06-21 2015-05-19 Traxtal Inc. Dispositif et methode pour ultrason detectable
US8632461B2 (en) 2005-06-21 2014-01-21 Koninklijke Philips N.V. System, method and apparatus for navigated therapy and diagnosis
US10052497B2 (en) * 2005-07-22 2018-08-21 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
US9274099B2 (en) 2005-07-22 2016-03-01 The Board Of Trustees Of The Leland Stanford Junior University Screening test drugs to identify their effects on cell membrane voltage-gated ion channel
US9238150B2 (en) * 2005-07-22 2016-01-19 The Board Of Trustees Of The Leland Stanford Junior University Optical tissue interface method and apparatus for stimulating cells
WO2007024391A2 (fr) 2005-07-22 2007-03-01 The Board Of Trustees Of The Leland Stanford Junior University Canaux cationiques activees par la lumiere et leurs utilisations
US8926959B2 (en) 2005-07-22 2015-01-06 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
US20070027486A1 (en) * 2005-07-29 2007-02-01 Cyberonics, Inc. Medical devices for enhancing intrinsic neural activity
US7499752B2 (en) * 2005-07-29 2009-03-03 Cyberonics, Inc. Selective nerve stimulation for the treatment of eating disorders
US20070027499A1 (en) * 2005-07-29 2007-02-01 Cyberonics, Inc. Neurostimulation device for treating mood disorders
WO2007025081A2 (fr) 2005-08-24 2007-03-01 Traxtal Inc. Systeme procede et dispositifs d'endoscopie souple de navigation
US20070073361A1 (en) * 2005-09-23 2007-03-29 Bioq, Inc. Medical device for restoration of autonomic and immune functions impaired by neuropathy
US8929991B2 (en) 2005-10-19 2015-01-06 Advanced Neuromodulation Systems, Inc. Methods for establishing parameters for neural stimulation, including via performance of working memory tasks, and associated kits
US7729773B2 (en) 2005-10-19 2010-06-01 Advanced Neuromodualation Systems, Inc. Neural stimulation and optical monitoring systems and methods
US7620455B2 (en) 2005-10-25 2009-11-17 Cyberonics, Inc. Cranial nerve stimulation to treat eating disorders
US20070100411A1 (en) * 2005-10-27 2007-05-03 Medtronic, Inc. Implantable medical electrical stimulation lead fixation method and apparatus
US7555344B2 (en) * 2005-10-28 2009-06-30 Cyberonics, Inc. Selective neurostimulation for treating epilepsy
US8589316B2 (en) 2009-08-27 2013-11-19 The Cleveland Clinic Foundation System and method to estimate region of tissue activation
US20070142872A1 (en) * 2005-12-21 2007-06-21 Mickle Marlin H Deep brain stimulation apparatus, and associated methods
US20070173890A1 (en) * 2006-01-24 2007-07-26 Cyberonics, Inc. Stimulation mode adjustment for an implantable medical device
US7996079B2 (en) 2006-01-24 2011-08-09 Cyberonics, Inc. Input response override for an implantable medical device
US7974697B2 (en) * 2006-01-26 2011-07-05 Cyberonics, Inc. Medical imaging feedback for an implantable medical device
US7801601B2 (en) * 2006-01-27 2010-09-21 Cyberonics, Inc. Controlling neuromodulation using stimulus modalities
WO2007106692A2 (fr) * 2006-03-15 2007-09-20 University Of Pittsbugh Of The Commonwealth System Of Higher Education Appareil de stimulation du nerf vague et procédés associés
EP3069752B1 (fr) 2006-03-29 2018-03-28 Dignity Health Stimulation électrique par microsalves de nerfs crâniens pour le traitement d'états médicaux
US7962220B2 (en) * 2006-04-28 2011-06-14 Cyberonics, Inc. Compensation reduction in tissue stimulation therapy
US7869885B2 (en) 2006-04-28 2011-01-11 Cyberonics, Inc Threshold optimization for tissue stimulation therapy
WO2007138598A2 (fr) * 2006-06-01 2007-12-06 Tylerton International Inc. Stimulation et réhabilitation du cerveau
US7869867B2 (en) 2006-10-27 2011-01-11 Cyberonics, Inc. Implantable neurostimulator with refractory stimulation
JP5557450B2 (ja) * 2006-11-02 2014-07-23 協和メデックス株式会社 測定対象成分の免疫測定法
US20080154331A1 (en) * 2006-12-21 2008-06-26 Varghese John Device for multicentric brain modulation, repair and interface
US8398692B2 (en) 2007-01-10 2013-03-19 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
WO2008101128A1 (fr) 2007-02-14 2008-08-21 The Board Of Trustees Of The Leland Stanford Junior University Système, procédé et applications comprenant l'identification de circuits biologiques tels que des caractéristiques neurologiques
WO2008106694A2 (fr) 2007-03-01 2008-09-04 The Board Of Trustees Of The Leland Stanford Junior University Systèmes, procédés et compositions pour stimulation optique de cellules cibles
RU2467773C2 (ru) * 2007-03-02 2012-11-27 Сапиенс Стиринг Брейн Стимьюлейшн Б.В. Система электродов для глубокой стимуляции головного мозга
US7974701B2 (en) 2007-04-27 2011-07-05 Cyberonics, Inc. Dosing limitation for an implantable medical device
DE102007024819B4 (de) * 2007-05-29 2011-07-28 OKM GmbH, 04603 Anordnung zur Unterstützung, Stimulierung und Beeinflussung von Gehirnaktivitäten
KR100897528B1 (ko) * 2007-06-22 2009-05-15 주식회사 사이버메드 디비에스 전극의 위치 판단 방법
US20090054955A1 (en) * 2007-08-20 2009-02-26 Kopell Brian H Systems and Methods for Treating Neurological Disorders by Light Stimulation
US10434327B2 (en) 2007-10-31 2019-10-08 The Board Of Trustees Of The Leland Stanford Junior University Implantable optical stimulators
US10035027B2 (en) * 2007-10-31 2018-07-31 The Board Of Trustees Of The Leland Stanford Junior University Device and method for ultrasonic neuromodulation via stereotactic frame based technique
US9248280B2 (en) * 2007-11-02 2016-02-02 Boston Scientific Neuromodulation Corporation Closed-loop feedback for steering stimulation energy within tissue
US20090118786A1 (en) * 2007-11-02 2009-05-07 Advanced Bionics Corporation Automated fitting system for deep brain stimulation
US20090118804A1 (en) * 2007-11-05 2009-05-07 Advanced Bionics Corporation Method of mounting minimally invasive plug electrodes within cranium of patient
US20090125080A1 (en) * 2007-11-12 2009-05-14 Montgomery Jr Erwin B Intraventricular electrodes for electrical stimulation of the brain
US9579506B2 (en) 2008-01-25 2017-02-28 Flint Hills Scientific, L.L.C. Contingent cardio-protection for epilepsy patients
US8382667B2 (en) 2010-10-01 2013-02-26 Flint Hills Scientific, Llc Detecting, quantifying, and/or classifying seizures using multimodal data
US8337404B2 (en) 2010-10-01 2012-12-25 Flint Hills Scientific, Llc Detecting, quantifying, and/or classifying seizures using multimodal data
US8571643B2 (en) 2010-09-16 2013-10-29 Flint Hills Scientific, Llc Detecting or validating a detection of a state change from a template of heart rate derivative shape or heart beat wave complex
US9220889B2 (en) 2008-02-11 2015-12-29 Intelect Medical, Inc. Directional electrode devices with locating features
US8019440B2 (en) 2008-02-12 2011-09-13 Intelect Medical, Inc. Directional lead assembly
AU2009238467B2 (en) * 2008-04-23 2015-06-25 The Board Of Trustees Of The Leland Stanford Junior University Systems, methods and compositions for optical stimulation of target cells
US8204603B2 (en) 2008-04-25 2012-06-19 Cyberonics, Inc. Blocking exogenous action potentials by an implantable medical device
US9272153B2 (en) 2008-05-15 2016-03-01 Boston Scientific Neuromodulation Corporation VOA generation system and method using a fiber specific analysis
CN102076866A (zh) 2008-05-29 2011-05-25 利兰·斯坦福青年大学托管委员会 光学控制第二信使的细胞系、系统和方法
JP2011525130A (ja) 2008-06-17 2011-09-15 ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ 光伝送素子を用いた標的細胞の光刺激のための方法、システム、および装置
MX2010014101A (es) * 2008-06-17 2011-03-04 Univ Leland Stanford Junior Aparato y metodos para controlar el desarrollo celular.
US9101759B2 (en) 2008-07-08 2015-08-11 The Board Of Trustees Of The Leland Stanford Junior University Materials and approaches for optical stimulation of the peripheral nervous system
EP2313148B1 (fr) 2008-07-30 2013-08-21 Ecole Polytechnique Fédérale de Lausanne Appareil de stimulation optimisee d'une cible neurologique
US9662502B2 (en) 2008-10-14 2017-05-30 Great Lakes Neurotechnologies Inc. Method and system for tuning of movement disorder therapy devices
US9393418B2 (en) 2011-06-03 2016-07-19 Great Lakes Neuro Technologies Inc. Movement disorder therapy system, devices and methods of tuning
US8457747B2 (en) 2008-10-20 2013-06-04 Cyberonics, Inc. Neurostimulation with signal duration determined by a cardiac cycle
US8417344B2 (en) 2008-10-24 2013-04-09 Cyberonics, Inc. Dynamic cranial nerve stimulation based on brain state determination from cardiac data
EP2370160A1 (fr) * 2008-10-29 2011-10-05 Sorin CRM SAS Stimulation cardiaque optimale avec apprentissage q
AU2009315316B2 (en) 2008-11-12 2015-11-05 Ecole Polytechnique Federale De Lausanne Microfabricated neurostimulation device
NZ602416A (en) 2008-11-14 2014-08-29 Univ Leland Stanford Junior Optically-based stimulation of target cells and modifications thereto
US20100191304A1 (en) 2009-01-23 2010-07-29 Scott Timothy L Implantable Medical Device for Providing Chronic Condition Therapy and Acute Condition Therapy Using Vagus Nerve Stimulation
US20140255461A9 (en) * 2009-02-10 2014-09-11 Richard Jay McMurtrey Decorin and Gliosis and Related System and Method
US8396558B2 (en) * 2009-02-11 2013-03-12 University Of Maryland, Baltimore Methods for treating central pain syndrome and other pain related pathologies
EP2411090B1 (fr) 2009-03-22 2015-08-19 Sorin CRM SAS Thérapie de stimulation cérébrale profonde optimale avec apprentissage q
US8827912B2 (en) 2009-04-24 2014-09-09 Cyberonics, Inc. Methods and systems for detecting epileptic events using NNXX, optionally with nonlinear analysis parameters
US8239028B2 (en) 2009-04-24 2012-08-07 Cyberonics, Inc. Use of cardiac parameters in methods and systems for treating a chronic medical condition
WO2011000791A1 (fr) 2009-06-29 2011-01-06 3Win N.V. Fil atraumatique pour stimulation cérébrale profonde
CA3026948C (fr) 2009-12-01 2022-07-12 Ecole Polytechnique Federale De Lausanne Dispositif de neurostimulation microfabrique et ses procedes de fabrication et d'utilisation
WO2011068997A1 (fr) 2009-12-02 2011-06-09 The Cleveland Clinic Foundation Détériorations cognitives-motrices réversibles chez des patients atteints d'une maladie neuro-dégénérative à l'aide d'une approche de modélisation informatique pour une programmation de stimulation cérébrale profonde
EP2528503B1 (fr) * 2010-01-26 2014-07-16 Sapiens Steering Brain Stimulation B.V. Système et procédé pour déterminer une orientation d'un stimulateur biomédical
EP3399024A1 (fr) 2010-03-17 2018-11-07 The Board of Trustees of The Leland Stanford Junior University Molécules laissant passer les ions sensibles à la lumière
JP5927176B2 (ja) 2010-04-01 2016-06-01 エコーレ ポリテクニーク フェデラーレ デ ローザンヌ （イーピーエフエル） 神経組織と相互作用するためのデバイス、ならびにそれを作製および使用する方法
US8562536B2 (en) 2010-04-29 2013-10-22 Flint Hills Scientific, Llc Algorithm for detecting a seizure from cardiac data
US8831732B2 (en) 2010-04-29 2014-09-09 Cyberonics, Inc. Method, apparatus and system for validating and quantifying cardiac beat data quality
US8649871B2 (en) 2010-04-29 2014-02-11 Cyberonics, Inc. Validity test adaptive constraint modification for cardiac data used for detection of state changes
US8913804B2 (en) 2010-06-14 2014-12-16 Boston Scientific Neuromodulation Corporation Programming interface for spinal cord neuromodulation
US8679009B2 (en) 2010-06-15 2014-03-25 Flint Hills Scientific, Llc Systems approach to comorbidity assessment
US10085689B1 (en) 2010-06-18 2018-10-02 Great Lakes NeuroTechnolgies Inc. Device and method for monitoring and assessment of movement disorder symptoms
US8641646B2 (en) 2010-07-30 2014-02-04 Cyberonics, Inc. Seizure detection using coordinate data
US8805519B2 (en) 2010-09-30 2014-08-12 Nevro Corporation Systems and methods for detecting intrathecal penetration
US8965482B2 (en) 2010-09-30 2015-02-24 Nevro Corporation Systems and methods for positioning implanted devices in a patient
US8684921B2 (en) 2010-10-01 2014-04-01 Flint Hills Scientific Llc Detecting, assessing and managing epilepsy using a multi-variate, metric-based classification analysis
WO2012061688A1 (fr) 2010-11-05 2012-05-10 The Board Of Trustees Of The Leland Stanford Junior University Régulation optogénétique de comportements associés à la récompense
EP2635111B1 (fr) 2010-11-05 2018-05-23 The Board of Trustees of the Leland Stanford Junior University Protéines stabilisées de type opsine a fonction discontinue (ssfo) et leurs procédés d'utilisation
US10086012B2 (en) 2010-11-05 2018-10-02 The Board Of Trustees Of The Leland Stanford Junior University Control and characterization of memory function
AU2011323237B2 (en) 2010-11-05 2015-11-12 The Board Of Trustees Of The Leland Stanford Junior University Optically-controlled CNS dysfunction
WO2012061684A1 (fr) 2010-11-05 2012-05-10 The Board Of Trustees Of The Leland Stanford Junior University Montée en fréquence de la lumière pour l'utilisation dans des procédés optogénétiques
CA2816971A1 (fr) 2010-11-05 2012-05-10 The Board Of Trustees Of The Leland Stanford Junior University Opsines chimeriques activees par la lumiere et leurs procedes d'utilisation
US8696722B2 (en) 2010-11-22 2014-04-15 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic magnetic resonance imaging
US9504390B2 (en) 2011-03-04 2016-11-29 Globalfoundries Inc. Detecting, assessing and managing a risk of death in epilepsy
US8676343B2 (en) 2011-03-10 2014-03-18 Biotronik Se & Co. Kg Multi-electrode leads for brain implantation
EP2691900A2 (fr) 2011-03-29 2014-02-05 Boston Scientific Neuromodulation Corporation Système et procédé d'enregistrement d'image
US8725239B2 (en) 2011-04-25 2014-05-13 Cyberonics, Inc. Identifying seizures using heart rate decrease
US9402550B2 (en) 2011-04-29 2016-08-02 Cybertronics, Inc. Dynamic heart rate threshold for neurological event detection
CA2835486C (fr) 2011-05-13 2022-07-19 Saluda Medical Pty Limited Methode et appareil de mesure de la reponse neuronale -a
WO2012155184A1 (fr) 2011-05-13 2012-11-22 National Ict Australia Ltd Méthode et appareil de mesure de la réponse neuronale
US10568559B2 (en) 2011-05-13 2020-02-25 Saluda Medical Pty Ltd Method and apparatus for measurement of neural response
US9592389B2 (en) 2011-05-27 2017-03-14 Boston Scientific Neuromodulation Corporation Visualization of relevant stimulation leadwire electrodes relative to selected stimulation information
US8751008B2 (en) 2011-08-09 2014-06-10 Boston Scientific Neuromodulation Corporation Remote control data management with correlation of patient condition to stimulation settings and/or with clinical mode providing a mismatch between settings and interface data
US10206591B2 (en) 2011-10-14 2019-02-19 Flint Hills Scientific, Llc Seizure detection methods, apparatus, and systems using an autoregression algorithm
AU2012352429B2 (en) 2011-12-16 2018-07-19 The Board Of Trustees Of The Leland Stanford Junior University Opsin polypeptides and methods of use thereof
WO2013102180A1 (fr) 2011-12-30 2013-07-04 Neurotrek, Inc. Optimisation de caractéristiques de forme d'onde ultrasonore pour une neuromodulation par ultrasons transcrâniens
WO2013126521A1 (fr) 2012-02-21 2013-08-29 The Board Of Trustees Of The Leland Stanford Junior University Compositions et méthodes destinées à traiter les troubles neurogènes du plancher pelvien
US10448839B2 (en) 2012-04-23 2019-10-22 Livanova Usa, Inc. Methods, systems and apparatuses for detecting increased risk of sudden death
EP2879757B1 (fr) 2012-08-04 2019-06-26 Boston Scientific Neuromodulation Corporation Systèmes et procédés de stockage et de transfert d'informations d'enregistrement, d'atlas et de dérivation entre des dispositifs médicaux
US11167154B2 (en) 2012-08-22 2021-11-09 Medtronic, Inc. Ultrasound diagnostic and therapy management system and associated method
ES2655549T3 (es) 2012-08-28 2018-02-20 Boston Scientific Neuromodulation Corporation Programación de apuntar y hacer clic para estimulación cerebral profunda usando líneas de tendencia de revisión monopolar en tiempo real
US9238142B2 (en) 2012-09-10 2016-01-19 Great Lakes Neurotechnologies Inc. Movement disorder therapy system and methods of tuning remotely, intelligently and/or automatically
WO2014040023A1 (fr) * 2012-09-10 2014-03-13 Great Lakes Neurotechnologies Inc. Système de thérapie d'un trouble du mouvement et procédés de réglage à distance, de façon intelligente et/ou automatique
US11844945B1 (en) * 2012-09-10 2023-12-19 Great Lakes Neurotechnologies Inc. Movement disorder therapy system, devices and methods of remotely tuning
US9295838B2 (en) 2012-10-31 2016-03-29 The Regents Of The University Of California Methods and systems for treating neurological movement disorders
WO2014070290A2 (fr) 2012-11-01 2014-05-08 Boston Scientific Neuromodulation Corporation Systèmes et procédés de génération et d'utilisation de modèle voa
US10220211B2 (en) 2013-01-22 2019-03-05 Livanova Usa, Inc. Methods and systems to diagnose depression
AU2014227600B2 (en) 2013-03-15 2018-10-04 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic control of behavioral state
US9636380B2 (en) 2013-03-15 2017-05-02 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic control of inputs to the ventral tegmental area
CN105431046B (zh) 2013-04-29 2020-04-17 小利兰·斯坦福大学托管委员会 用于靶细胞中的动作电位的光遗传学调节的装置、系统和方法
JP6621747B2 (ja) 2013-08-14 2019-12-18 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 疼痛を制御するための組成物及び方法
EP3068296A4 (fr) 2013-11-15 2017-07-19 Saluda Medical Pty Limited Monitorage des potentiels d'action neuronaux dans le cerveau
US11311718B2 (en) 2014-05-16 2022-04-26 Aleva Neurotherapeutics Sa Device for interacting with neurological tissue and methods of making and using the same
WO2015173787A1 (fr) 2014-05-16 2015-11-19 Aleva Neurotherapeutics Sa Dispositif pour l'interaction avec un tissu neurologique et procédés de fabrication et d'utilisation associés
US9959388B2 (en) 2014-07-24 2018-05-01 Boston Scientific Neuromodulation Corporation Systems, devices, and methods for providing electrical stimulation therapy feedback
EP3838331B1 (fr) 2014-07-25 2024-05-22 Saluda Medical Pty Limited Dosage de stimulation neurale
US10265528B2 (en) 2014-07-30 2019-04-23 Boston Scientific Neuromodulation Corporation Systems and methods for electrical stimulation-related patient population volume analysis and use
US10272247B2 (en) 2014-07-30 2019-04-30 Boston Scientific Neuromodulation Corporation Systems and methods for stimulation-related volume analysis, creation, and sharing with integrated surgical planning and stimulation programming
US9474894B2 (en) 2014-08-27 2016-10-25 Aleva Neurotherapeutics Deep brain stimulation lead
US9403011B2 (en) 2014-08-27 2016-08-02 Aleva Neurotherapeutics Leadless neurostimulator
WO2016057544A1 (fr) 2014-10-07 2016-04-14 Boston Scientific Neuromodulation Corporation Systèmes, dispositifs et procédés de stimulation électrique à l'aide d'une rétroaction pour régler des paramètres de stimulation
US11006846B2 (en) 2014-11-17 2021-05-18 Saluda Medical Pty Ltd Method and device for detecting a neural response in neural measurements
WO2016090420A1 (fr) 2014-12-11 2016-06-16 Saluda Medical Pty Ltd Positionnement d'électrode implantable
US10918872B2 (en) 2015-01-19 2021-02-16 Saluda Medical Pty Ltd Method and device for neural implant communication
US10894158B2 (en) 2015-04-09 2021-01-19 Saluda Medical Pty Ltd Electrode to nerve distance estimation
US11234632B2 (en) 2015-05-10 2022-02-01 Alpha Omega Engineering Ltd. Brain navigation lead
US11051889B2 (en) 2015-05-10 2021-07-06 Alpha Omega Engineering Ltd. Brain navigation methods and device
US10932862B2 (en) 2015-05-10 2021-03-02 Alpha Omega Neuro Technologies Ltd. Automatic brain probe guidance system
EP3268082B1 (fr) 2015-05-26 2019-04-17 Boston Scientific Neuromodulation Corporation Systèmes et procédés d'analyse de stimulation électrique et de sélection ou de manipulation de volumes d'activation
US10780283B2 (en) 2015-05-26 2020-09-22 Boston Scientific Neuromodulation Corporation Systems and methods for analyzing electrical stimulation and selecting or manipulating volumes of activation
JP2018516150A (ja) 2015-05-31 2018-06-21 サルーダ・メディカル・ピーティーワイ・リミテッド 脳神経活動の監視
CA2980482C (fr) 2015-06-01 2023-09-26 Saluda Medical Pty Ltd Neuromodulation des fibres motrices
US10568516B2 (en) 2015-06-22 2020-02-25 The Board Of Trustees Of The Leland Stanford Junior University Methods and devices for imaging and/or optogenetic control of light-responsive neurons
EP3280490B1 (fr) 2015-06-29 2021-09-01 Boston Scientific Neuromodulation Corporation Systèmes de sélection de paramètres de stimulation sur la base de région cible de stimulation, d'effets ou d'effets secondaires
WO2017003947A1 (fr) 2015-06-29 2017-01-05 Boston Scientific Neuromodulation Corporation Systèmes et procédés de sélection de paramètres de stimulation par ciblage et guidage
US10071249B2 (en) 2015-10-09 2018-09-11 Boston Scientific Neuromodulation Corporation System and methods for clinical effects mapping for directional stimulation leads
EP3411111A1 (fr) 2016-02-02 2018-12-12 Aleva Neurotherapeutics SA Traitement de maladies auto-immunes par stimulation cérébrale profonde
WO2017173493A1 (fr) 2016-04-05 2017-10-12 Saluda Medical Pty Ltd Commande de rétroaction améliorée de neuromodulation
US10716942B2 (en) 2016-04-25 2020-07-21 Boston Scientific Neuromodulation Corporation System and methods for directional steering of electrical stimulation
US11179091B2 (en) 2016-06-24 2021-11-23 Saluda Medical Pty Ltd Neural stimulation for reduced artefact
EP3458152B1 (fr) 2016-06-24 2021-04-21 Boston Scientific Neuromodulation Corporation Systèmes et procédés pour l'analyse visuelle d'effets cliniques
WO2018044881A1 (fr) 2016-09-02 2018-03-08 Boston Scientific Neuromodulation Corporation Systèmes et procédés de visualisation et d'orientation de la stimulation d'éléments neuronaux
US10780282B2 (en) 2016-09-20 2020-09-22 Boston Scientific Neuromodulation Corporation Systems and methods for steering electrical stimulation of patient tissue and determining stimulation parameters
ES2869184T3 (es) 2016-10-14 2021-10-25 Boston Scient Neuromodulation Corp Sistemas para determinar en lazo cerrado la configuración de los parámetros de estimulación de un sistema de estimulación eléctrica
AU2017391436B2 (en) 2017-01-03 2020-06-18 Boston Scientific Neuromodulation Corporation Systems and methods for selecting MRI-compatible stimulation parameters
WO2018132334A1 (fr) 2017-01-10 2018-07-19 Boston Scientific Neuromodulation Corporation Systèmes et procédés pour créer des programmes de stimulation basés sur des zones ou des volumes définis par l'utilisateur
AU2018231031B2 (en) 2017-03-09 2023-11-02 Nevro Corp. Paddle leads and delivery tools, and associated systems and methods
US10625082B2 (en) 2017-03-15 2020-04-21 Boston Scientific Neuromodulation Corporation Visualization of deep brain stimulation efficacy
US11294165B2 (en) 2017-03-30 2022-04-05 The Board Of Trustees Of The Leland Stanford Junior University Modular, electro-optical device for increasing the imaging field of view using time-sequential capture
US11357986B2 (en) 2017-04-03 2022-06-14 Boston Scientific Neuromodulation Corporation Systems and methods for estimating a volume of activation using a compressed database of threshold values
AU2018301355B2 (en) 2017-07-14 2020-10-01 Boston Scientific Neuromodulation Corporation Systems and methods for estimating clinical effects of electrical stimulation
US10960214B2 (en) 2017-08-15 2021-03-30 Boston Scientific Neuromodulation Corporation Systems and methods for controlling electrical stimulation using multiple stimulation fields
US10987016B2 (en) * 2017-08-23 2021-04-27 The Boeing Company Visualization system for deep brain stimulation
US10702692B2 (en) 2018-03-02 2020-07-07 Aleva Neurotherapeutics Neurostimulation device
WO2019191423A1 (fr) 2018-03-29 2019-10-03 Nevro Corp. Fils ayant des ouvertures de paroi latérale ainsi que systèmes et procédés associés
EP3784338A4 (fr) 2018-04-27 2022-01-19 Saluda Medical Pty Ltd Neurostimulation de nerfs mixtes
EP3784332B1 (fr) 2018-04-27 2023-04-26 Boston Scientific Neuromodulation Corporation Systèmes de visualisation et de programmation de la stimulation électrique
EP3784331B1 (fr) 2018-04-27 2023-01-18 Boston Scientific Neuromodulation Corporation Systèmes de stimulation électrique multimode et leurs procédés de fabrication et d'utilisation
US11452864B2 (en) 2019-05-20 2022-09-27 Biopro Scientific Co., Ltd. Method and system for treating neural disorders
EP3750592B1 (fr) 2019-05-20 2024-07-03 Biopro Scientific Co., Ltd. Système de traitement des troubles du mouvement
US20220266017A1 (en) * 2019-07-30 2022-08-25 Université de Montréal Systems and Methods For Movement Modulation of a Body Part of a Subject
US11484718B2 (en) 2021-01-22 2022-11-01 Ruse Technologies, Llc Multimode ICD system comprising phased array amplifiers to treat and manage CRT, CHF, and PVC disorders using ventricle level-shifting therapy to minimize VT/VF and SCA

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3825015A (en) 1972-12-14 1974-07-23 American Optical Corp Single catheter for atrial and ventricular stimulation
CA1065969A (fr) 1977-09-28 1979-11-06 Gratien Bouillon Sonde cerebrale auto-bloquante
US4735205A (en) 1986-02-24 1988-04-05 Medtronic, Inc. Method and apparatus including a sliding insulation lead for cardiac assistance
US5065083A (en) * 1989-08-25 1991-11-12 Staodyn, Inc. Microprocessor controlled electronic stimulating device having a battery management system and method therefor
JPH09508553A (ja) * 1994-02-09 1997-09-02 ユニヴァーシティ オブ アイオワ リサーチ ファンデーション ヒト大脳皮質神経補てつ物
US5697975A (en) * 1994-02-09 1997-12-16 The University Of Iowa Research Foundation Human cerebral cortex neural prosthetic for tinnitus
US5843093A (en) * 1994-02-09 1998-12-01 University Of Iowa Research Foundation Stereotactic electrode assembly
US5674274A (en) * 1995-12-14 1997-10-07 Pacesetter, Inc. Implantable adjustable single-pass A-V lead for use with an implantable stimulation device
US5824030A (en) * 1995-12-21 1998-10-20 Pacesetter, Inc. Lead with inter-electrode spacing adjustment
US6066163A (en) * 1996-02-02 2000-05-23 John; Michael Sasha Adaptive brain stimulation method and system
US5713922A (en) * 1996-04-25 1998-02-03 Medtronic, Inc. Techniques for adjusting the locus of excitation of neural tissue in the spinal cord or brain
US5925070A (en) * 1996-04-04 1999-07-20 Medtronic, Inc. Techniques for adjusting the locus of excitation of electrically excitable tissue
US5702429A (en) * 1996-04-04 1997-12-30 Medtronic, Inc. Neural stimulation techniques with feedback
US5716377A (en) * 1996-04-25 1998-02-10 Medtronic, Inc. Method of treating movement disorders by brain stimulation
US5713923A (en) * 1996-05-13 1998-02-03 Medtronic, Inc. Techniques for treating epilepsy by brain stimulation and drug infusion
US5752979A (en) * 1996-11-01 1998-05-19 Medtronic, Inc. Method of controlling epilepsy by brain stimulation
US6011996A (en) 1998-01-20 2000-01-04 Medtronic, Inc Dual electrode lead and method for brain target localization in functional stereotactic brain surgery
US5948014A (en) * 1998-01-23 1999-09-07 Pacesetter, Inc. Implantable stimulation system having a single-pass, tripolar lead and programmable polarity
US6027456A (en) * 1998-07-10 2000-02-22 Advanced Neuromodulation Systems, Inc. Apparatus and method for positioning spinal cord stimulation leads
US6405079B1 (en) * 2000-09-22 2002-06-11 Mehdi M. Ansarinia Stimulation method for the dural venous sinuses and adjacent dura for treatment of medical conditions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None

Cited By (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7010351B2 (en) 2000-07-13 2006-03-07 Northstar Neuroscience, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US7756584B2 (en) 2000-07-13 2010-07-13 Advanced Neuromodulation Systems, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
EP1341579B1 (fr) * 2000-12-07 2006-11-29 Medtronic, Inc. Stimulation directionnelle du cerveau et broches de raccordement
US7672730B2 (en) 2001-03-08 2010-03-02 Advanced Neuromodulation Systems, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US7831305B2 (en) 2001-10-15 2010-11-09 Advanced Neuromodulation Systems, Inc. Neural stimulation system and method responsive to collateral neural activity
US6959215B2 (en) * 2002-12-09 2005-10-25 Northstar Neuroscience, Inc. Methods for treating essential tremor
US8517908B2 (en) 2003-03-07 2013-08-27 Neuronetics, Inc. Reducing discomfort caused by electrical stimulation
US10413745B2 (en) 2003-03-07 2019-09-17 Neuronetics, Inc. Reducing discomfort caused by electrical stimulation
US8864641B2 (en) 2003-03-07 2014-10-21 Neuronetics, Inc. Reducing discomfort caused by electrical stimulation
US7107104B2 (en) 2003-05-30 2006-09-12 Medtronic, Inc. Implantable cortical neural lead and method
US7684866B2 (en) 2003-08-01 2010-03-23 Advanced Neuromodulation Systems, Inc. Apparatus and methods for applying neural stimulation to a patient
US7104947B2 (en) 2003-11-17 2006-09-12 Neuronetics, Inc. Determining stimulation levels for transcranial magnetic stimulation
US7651459B2 (en) 2004-01-06 2010-01-26 Neuronetics, Inc. Method and apparatus for coil positioning for TMS studies
US8177702B2 (en) 2004-04-15 2012-05-15 Neuronetics, Inc. Method and apparatus for determining the proximity of a TMS coil to a subject's head
US10596385B2 (en) 2004-04-15 2020-03-24 Neuronetics, Inc. Method and apparatus for determining the proximity of a TMS coil to a subject's head
US9421392B2 (en) 2004-04-15 2016-08-23 Neuronetics, Inc. Method and apparatus for determining the proximity of a TMS coil to a subject's head
US9681841B2 (en) 2004-04-15 2017-06-20 Neuronetics, Inc. Method and apparatus for determining the proximity of a TMS coil to a subject's head
US11786729B2 (en) 2004-07-15 2023-10-17 Advanced Neuromodulation Systems, Inc. Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy
US8088058B2 (en) 2005-01-20 2012-01-03 Neuronetics, Inc. Articulating arm
US11185710B2 (en) 2005-05-17 2021-11-30 Neuronetics, Inc. Ferrofluidic cooling and acoustical noise reduction in magnetic stimulators
US10315041B2 (en) 2005-05-17 2019-06-11 Neuronetics, Inc. Ferrofluidic cooling and acoustical noise reduction in magnetic stimulators
US10617884B2 (en) 2005-07-27 2020-04-14 Neurontics, Inc. Magnetic core for medical procedures
US9308386B2 (en) 2005-07-27 2016-04-12 Neuronetics, Inc. Magnetic core for medical procedures
US9931518B2 (en) 2005-07-27 2018-04-03 Neuronetics, Inc. Magnetic core for medical procedures
US8657731B2 (en) 2005-07-27 2014-02-25 Neuronetics, Inc. Magnetic core for medical procedures
US7856264B2 (en) 2005-10-19 2010-12-21 Advanced Neuromodulation Systems, Inc. Systems and methods for patient interactive neural stimulation and/or chemical substance delivery
US8128549B2 (en) 2007-02-20 2012-03-06 Neuronetics, Inc. Capacitor failure detection
US9884200B2 (en) 2008-03-10 2018-02-06 Neuronetics, Inc. Apparatus for coil positioning for TMS studies
US11420064B2 (en) 2011-05-13 2022-08-23 Saluda Medical Pty Ltd Method and apparatus for application of a neural stimulus
US11413460B2 (en) 2011-05-13 2022-08-16 Saluda Medical Pty Ltd Method and apparatus for application of a neural stimulus
US11426587B2 (en) 2011-05-13 2022-08-30 Saluda Medical Pty Ltd Method and apparatus for application of a neural stimulus
US11439828B2 (en) 2011-05-13 2022-09-13 Saluda Medical Pty Ltd Method and apparatus for application of a neural stimulus
US11464979B2 (en) 2011-05-13 2022-10-11 Saluda Medical Pty Ltd Method and apparatus for application of a neural stimulus
US11944440B2 (en) 2011-05-13 2024-04-02 Saluda Medical Pty Ltd Method and apparatus for estimating neural recruitment
EP2892419A4 (fr) * 2012-09-10 2016-11-02 Great Lakes Neuro Technologies Inc Système, dispositifs et procédés de thérapie de trouble du mouvement, et procédés intelligents de réglage
US10039507B2 (en) 2012-09-19 2018-08-07 The Regents Of The University Of Michigan Advanced intraoperative neural targeting system and method
US11944439B2 (en) 2012-11-06 2024-04-02 Saluda Medical Pty Ltd Method and system for controlling electrical conditions of tissue
US10426409B2 (en) 2013-11-22 2019-10-01 Saluda Medical Pty Ltd Method and device for detecting a neural response in a neural measurement
US11890113B2 (en) 2013-11-22 2024-02-06 Saluda Medical Pty Ltd Method and device for detecting a neural response in a neural measurement
US10368762B2 (en) 2014-05-05 2019-08-06 Saluda Medical Pty Ltd. Neural measurement
US11344729B1 (en) 2014-12-11 2022-05-31 Saluda Medical Pty Ltd Method and device for feedback control of neural stimulation
US11464980B2 (en) 2014-12-11 2022-10-11 Saluda Medical Pty Ltd Method and device for feedback control of neural stimulation
JP2018516149A (ja) * 2015-05-31 2018-06-21 サルーダ・メディカル・ピーティーワイ・リミテッド 脳神経刺激装置電極の取付け

Also Published As

Publication number Publication date
US6253109B1 (en) 2001-06-26
EP0998958B1 (fr) 2005-08-03
US20010008972A1 (en) 2001-07-19
EP0998958A3 (fr) 2000-12-27
US6484059B2 (en) 2002-11-19
DE69926465D1 (de) 2005-09-08
DE69926465T2 (de) 2006-06-08

Similar Documents

Publication Publication Date Title
EP0998958B1 (fr) Système pour une stimulation cérébrale optimisée
US20230096192A1 (en) Systems and methods for determining a trajectory for a brain stimulation lead
US10307324B2 (en) Selective recruitment and activation of fiber types in nerves for the control of undesirable brain state changes
EP0971768B1 (fr) Conducteur a localisation de cible destine a la chirurgie stereotaxique du cerveau
US7981119B2 (en) Electrical stimulation system and associated apparatus for securing an electrical stimulation lead in position in a person's brain
Lenz et al. Methods for microstimulation and recording of single neurons and evoked potentials in the human central nervous system
US7212867B2 (en) Directional brain stimulation and recording leads
US20050246004A1 (en) Combination lead for electrical stimulation and sensing
US20010016765A1 (en) Method of Identifying Functional Boundaries Between Brain Structures
US20140288615A1 (en) First time right placement of a dbs lead
US20050049649A1 (en) Electrical stimulation of the brain
US20050246003A1 (en) Stimulation lead having pairs of stimulating electrodes spaced at different distances for providing electrical stimulation to different nerve tissues
WO2011011554A1 (fr) Procédés d'identification et de ciblage de régions et de structures du cerveau et traitements associés
EP0991366A1 (fr) Sonde d'obesite hypothalamique stereoactive
WO2004037342A2 (fr) Stimulation electrique du cerveau
Lozano et al. Microelectrode monitoring of cortical and subcortical structures during stereotactic surgery
EP1627659A1 (fr) Système et méthode de stimulation électrique pour stimuler du tissu de nerf dans le cerveau utilisant une conducteur de stimulation avec une électrode à pointe, avec au moins cinq électrodes, ou toutes les deux
Shill et al. Reliability in deep brain stimulation
Baltuch Anterior thalamic nucleus stimulation: surgical procedure
Goodwin et al. Microelectrode Recordings in Deep Brain Stimulation Surgery

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): DE FR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17P Request for examination filed

Effective date: 20010619

AKX Designation fees paid

Free format text: DE FR

17Q First examination report despatched

Effective date: 20040507

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MEDTRONIC, INC.

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): DE FR

REF Corresponds to:

Ref document number: 69926465

Country of ref document: DE

Date of ref document: 20050908

Kind code of ref document: P

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20060504

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20101130

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20111128

Year of fee payment: 13

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20130731

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 69926465

Country of ref document: DE

Effective date: 20130601

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130601

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20121130